RxDoctor Payments Data

Joanna Kurilla

Psychiatric/Mental Health · Maryville, ILNPI 1760052310

Payments from drug & device makers

$1,714in general payments, 2019–2025

Across 76 payments — averaging $22.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supernus Pharmaceuticals, Inc.$461
  • Axsome Therapeutics, Inc.$396
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$218
  • Otsuka America Pharmaceutical, Inc.$138
  • AbbVie$89
  • Livanova USA, Inc.$55
  • plus $358 from 12 others

What the payments were for

  • Food & beverage$1,59793%
  • Education$1177%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,714 in reported general payments places this provider in the 75th percentile of 922 psychiatric/mental health providers in Illinois.

See all psychiatric/mental health providers in Illinois

Medicare billing

Part B allowed, 2024
$30,407
Medicare patients
78
Services billed
576

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl36$61,527
CaplytaLumateperone Tosylate15$28,124
TrintellixVortioxetine Hydrobromide23$20,770
QelbreeViloxazine Hcl11$10,071
Aripiprazole74$9,733
BelsomraSuvorexant15$7,287
Atomoxetine Hcl35$4,990
Duloxetine Hcl108$2,987
Bupropion XlBupropion Hcl114$2,823
Quetiapine Fumarate114$2,559
Buspirone Hcl85$1,942
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl24$1,759
Sertraline Hcl119$1,415
Venlafaxine Hcl ErVenlafaxine Hcl53$1,240
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine17$945

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$89$61,52736 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$218$28,12415 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$31$20,77023 claims
Supernus Pharmaceuticals, Inc.Qelbree$461$10,07111 claims
MerckBelsomra$14$7,28715 claims
Lilly USA, LLCOlanzapine$33$54733 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 922 psychiatric/mental health providers in Illinois.

Other psychiatric/mental health in Maryville

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →